Article info
PDFNeurology in practice
THE BARE ESSENTIALS
Myasthenia gravis and other neuromuscular junction disorders
- Correspondence to Dr Saiju Jacob, Department of Neurology, Queen Elizabeth Neurosciences Centre, University Hospitals of Birmingham, B15 2TH, UK; saiju.jacob{at}nhs.net
Citation
Myasthenia gravis and other neuromuscular junction disorders
Publication history
- First published November 17, 2009.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd.
Other content recommended for you
- Persistent type 2 respiratory failure on background of advanced thymoma with lung metastases
- The use of rituximab in myasthenia gravis and Lambert–Eaton myasthenic syndrome
- Myasthenia and related disorders of the neuromuscular junction
- Update on myasthenia gravis
- THE NEUROMUSCULAR JUNCTION DISORDERS
- Clinical and serological study of myasthenia gravis in HuBei Province, China
- Myasthenia gravis presenting as bilateral pseudointernuclear ophthalmoplegia in a patient with an incidental prolactinoma
- Problem-solving in clinical practice: breathing difficulty and muscle weakness following allogeneic haematopoietic stem cell transplantation
- Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis
- New and emerging treatments for myasthenia gravis